Literature DB >> 10985652

Risk of development of tuberculosis in HIV-infected patients.

S Swaminathan1, R Ramachandran, G Baskaran, C N Paramasivan, U Ramanathan, P Venkatesan, R Prabhakar, M Datta.   

Abstract

OBJECTIVE: To estimate the rate of development of active tuberculosis (TB) in a cohort of human immunodeficiency virus (HIV) positive patients, and to identify the characteristics of these patients.
DESIGN: A total of 175 HIV-positive individuals were recruited from clinics for sexually transmitted diseases and followed up for 31 +/- 6.8 months. Clinical examination, chest X-ray, sputum smear for acid-fast bacilli and culture for mycobacteria and HIV serology were performed at the time of registration and repeated periodically.
RESULTS: Seventeen patients had TB at intake and another 24 developed TB during follow-up, giving a breakdown rate of 6.9/100 person-years (p-y) (95% confidence interval [CI] 4.1-9.6). The attack rates were similar in tuberculin positive (7.1/100 p-y, 95%CI 3.4-10.8) and negative (6.7/100 p-y, 95%CI 2.6-10.8) patients. There was a trend towards higher mortality in patients who developed TB (10.5/100 p-y, 95%CI 4.8-15.2) compared to those who did not (6.1/100 p-y, 95%CI 3.2-8.8).
CONCLUSIONS: The results of this study provide information regarding the high risk of development of active tuberculosis and its associated mortality in HIV-infected persons. The risk of developing TB appears to be equally high in tuberculin positive and negative individuals, suggesting that new infections could play a major role in this susceptible population.

Entities:  

Mesh:

Year:  2000        PMID: 10985652

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  20 in total

Review 1.  Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.

Authors:  Satria A Prabowo; Matthias I Gröschel; Ed D L Schmidt; Alena Skrahina; Traian Mihaescu; Serap Hastürk; Rotislav Mitrofanov; Edita Pimkina; Ildikó Visontai; Bouke de Jong; John L Stanford; Père-Joan Cardona; Stefan H E Kaufmann; Tjip S van der Werf
Journal:  Med Microbiol Immunol       Date:  2012-11-10       Impact factor: 3.402

2.  Isoniazid for the Prevention of Tuberculosis in HIV-Infected Children: A Systematic Review and Meta-Analysis.

Authors:  Jaykaran Charan; Jagdish Prasad Goyal; Tea Reljic; Patricia Emmanuel; Atul Patel; Ambuj Kumar
Journal:  Pediatr Infect Dis J       Date:  2018-08       Impact factor: 2.129

3.  Lack of an Association Between Household Air Pollution Exposure and Previous Pulmonary Tuberculosis.

Authors:  Dennis Emuron; Trishul Siddharthan; Brooks Morgan; Suzanne L Pollard; Matthew R Grigsby; Dina Goodman; Muhammad Chowdhury; Adolfo Rubinstein; Vilma Irazola; Laura Gutierrez; J Jaime Miranda; Antonio Bernabe-Ortiz; Dewan Alam; Bruce Kirenga; Rupert Jones; Frederik van Gemert; William Checkley
Journal:  Lung       Date:  2019-10-03       Impact factor: 2.584

4.  Determination of Sites Involved, HIV Co-Infection & Utility of Diagnostic Modalities in EPTB.

Authors:  Aruna Shanmuganathan; Srinivasan R; Thilagavathy G; Satishkumar D; Sidduraj C; Bonny James
Journal:  J Clin Diagn Res       Date:  2013-08-01

5.  Interplay between HIV-1 and Host Genetic Variation: A Snapshot into Its Impact on AIDS and Therapy Response.

Authors:  Raghavan Sampathkumar; Elnaz Shadabi; Ma Luo
Journal:  Adv Virol       Date:  2012-05-16

Review 6.  Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis.

Authors:  Katharina Kranzer; Rein Mgj Houben; Judith R Glynn; Linda-Gail Bekker; Robin Wood; Stephen D Lawn
Journal:  Lancet Infect Dis       Date:  2010-02       Impact factor: 25.071

7.  Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.

Authors:  S Tripathy; A Anand; V Inamdar; M M Manoj; K M Khillare; A S Datye; R Iyer; D M Kanoj; M Thakar; V Kale; M Pereira; A R Risbud
Journal:  Indian J Med Res       Date:  2011-05       Impact factor: 2.375

8.  Antitubercular drug resistance in four healthcare facilities in North India.

Authors:  Anamika Gupta; Jitendra Prasad Mathuria; Surya Kumar Singh; Anil Kumar Gulati; Shampa Anupurba
Journal:  J Health Popul Nutr       Date:  2011-12       Impact factor: 2.000

9.  Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial.

Authors:  Soumya Swaminathan; Pradeep Aravindan Menon; Narendran Gopalan; Venkatesan Perumal; Ramesh Kumar Santhanakrishnan; Ranjani Ramachandran; Ponnuraja Chinnaiyan; Sheik Iliayas; Padmapriyadarsini Chandrasekaran; Pooranaganga Devi Navaneethapandian; Thiruvalluvan Elangovan; Mai Tuyet Pho; Fraser Wares; Narayanan Paranji Ramaiyengar
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

Review 10.  HIV and tuberculosis in India.

Authors:  Soumya Swaminathan; G Nagendran
Journal:  J Biosci       Date:  2008-11       Impact factor: 2.795

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.